An inverse correlation between hepatitis B virus (HBV) and steady-state levels of apolipoprotein AI and CIII mRNAs was observed in two hepatoma cell lines. Analysis of a third line containing an inducible viral genome implicated viral pregenomic RNA in apolipoprotein mRNA reduction. We conclude that HBV alters infected cells despite the absence of overt cytopathogenicity.
Chronic infection with hepatitis B virus (HBV) greatly increases the risk for developing liver cirrhosis and hepatocellular carcinoma (1, 2) . HBV infection is generally considered to be noncytopathic, as chronic viremia is not accompanied by signs of hepatocyte damage. Instead, considerable evidence points to an important immune and inflammatory contribution to liver dysfunction (5) . However, as virus pathology remains incompletely understood, it is possible that the replication of HBV and/or expression of viral gene products affects hepatocellular function at the molecular level. For example, the HBV transactivator, HBx, can activate a number of cellular genes (9) .
To probe for previously unrecognized interactions between HBV and host cells, RNA was isolated with Trizol (Invitrogen Life Technologies) from human HepG2 hepatoblastoma cells (American Type Culture Collection) and subline HepG2.2.15 cells. HepG2.2.15 cells are stably transfected with a complete HBV genome; they express all viral RNAs and proteins, produce viral genomes, and secrete virus-like particles (15) . DNA microarray analysis comparing the transcriptional profiles of the two cell lines was performed by a commercial service (Mergen, Ltd.). Of 1,059 genes queried on array H02, 72 mRNAs were up-regulated by twofold or more in the HepG2.2.15 cells and 87 were down-regulated. The latter group included multiple apolipoprotein genes normally expressed by hepatocytes; those apolipoprotein genes that produced signal above background in at least one of the two cell types are listed in Table  1 . Apolipoprotein AI (apoAI) represents the major protein component of high-density lipoprotein (HDL), and apoB represents the major protein constituent of very-low-density lipoprotein; both are normally secreted by hepatocytes. As HBV can be considered a lipoprotein particle itself, disruption of either type of normal lipoprotein secretion would represent an unusual host cell response to chronic viral infection.
RT-PCR was used to verify the down-regulation of selected liver-enriched apolipoprotein genes in HBV-expressing cells; apoCIII mRNA levels were also examined, as the apoCIII gene is adjacent to the apoAI gene and they share certain regulatory elements (19) . Reverse transcription (RT) was performed with 2 g of total RNA and 50 ng of random hexamer primers (11) . Five to 10% of each cDNA was used as a template in PCRs using gene-specific primers (sequences are available upon request) and Taq DNA polymerase (Stratagene). The number of cycles needed for each primer set to ensure that amplification was within the linear range was established empirically. PCR products were separated by electrophoresis through 2% agarose or 5% nondenaturing polyacrylamide gels and detected by ethidium bromide staining. Images were captured and relative quantitations were made with an AlphaImager digital imaging system (AlphaInnotech). Initial experiments confirmed the general trend of apolipoprotein mRNA reductions in HepG2.2.15 cells relative to levels in HepG2 cells (Fig. 1a) . However, the expression of viral genes in HepG2.2.15 cells is fairly low unless the cells are held at confluence for several days or more (15) , which may account for the magnitude of the difference in apolipoprotein mRNA levels determined by RT-PCR versus microarray analysis.
To investigate a possible inverse correlation between apolipoprotein mRNA levels and HBV levels, RNA was prepared from HepG2.2.15 cells maintained at confluence for increasing amounts of time. Dulbecco's modified Eagle's medium containing 10% fetal calf serum was replaced every other day to maintain cell viability. RT-PCR analysis revealed that levels of apoAI and apoCIII mRNAs declined strikingly with increasing time in culture; apoB mRNA levels declined slightly (Fig. 2) . In contrast, levels of viral pregenomic RNA increased over the same time period by a factor of ca. 10-fold. Actin mRNA levels remained constant during the first 7 days but declined by day 14. Transcription of cellular genes was not repressed globally, as no change was observed in ␣ 1 -antitrypsin mRNA abundance; this finding also suggests that hepatocyte-specific gene expression is not generally repressed. Thus, levels of apoAI and apoCIII mRNAs correlated inversely with levels of virus. Incubation of HepG2 monolayers for 7 or 14 days did not result in any change in apoAI mRNA levels (data not shown), demonstrating that the changes observed with HepG2.2.15 cells were not due to culture age or density. The reason for the discrepancy between the microarray and RT-PCR results for apoB is not known.
To strengthen the link between viral replication and apolipoprotein gene expression, a second cell pair was studied. Q7-21 cells were derived by transfection of a McA-RH7777 hepatoma cell subline with a full-length HBV genome (16) 
RT-PCR analysis demonstrated that levels of apoAI and apoCIII mRNAs were reduced in the virus-producing cells relative to the level in uninfected parental cells (Fig.  1b) . The level of apoB mRNA was also reduced, in contrast to the minimal effect seen with the HepG2.2.15 cells (Fig. 1a and  2 ). The two cell types differ in species, gender, and HBV subtype (adw2 for 2.2.15; ayw for Q7-21). In addition, HepG2 cells secrete apoB in abnormal particles that resemble LDL rather than very-low-density lipoprotein (17) , which might affect the response of the apoB gene to regulatory cues.
Concern remained that selection of cells capable of supporting virus replication and gene expression also selected for cellular changes that coincidentally reduced apolipoprotein gene expression. HepG2 AD38 cells contain a complete HBV genome under the control of a tetracycline-off promoter (13) . In the presence of tetracycline, these cells express low levels of the 3.5-kb pregenomic RNA that also serves as the mRNA for core protein and polymerase. The drug does not suppress the 2.5-and 2.1-kb surface glycoprotein transcripts, as they derive from transcription initiating at the internal pre-S1 and S promoters (Fig. 3a) .
RNA was isolated from HepG2 AD38 cells maintained in Dulbecco's modified Eagle's medium plus 10% fetal calf serum and tetracycline (Fig. 3b , day 0 with tetracycline). AD38 cells were seeded in triplicate and incubated in the absence of tetracycline for 2, 4, or 6 days prior to RNA isolation. A parallel culture was maintained for 6 days in the presence of tetracycline prior to RNA isolation to control for cell density and culture age effects. As expected from the published report, HBV pregenomic RNA was induced by 4 and 6 days following tetracycline withdrawal (Fig. 3b) . In contrast, levels of apoAI and apoCIII mRNAs declined following tetracycline withdrawal. The time-dependent reduction in apoAI and apoCIII mRNAs was not a consequence of cell density or aging, as cells incubated for the same length of time but in the presence of tetracycline to repress virus showed slightly elevated levels of these transcripts. Levels of apoB and actin mRNAs remained essentially unchanged over the 6-day time course. Tetracycline treatment of uninfected HepG2 cells did not affect apolipoprotein mRNA levels (data not shown). We conclude that apoAI and apoCIII steady-state mRNA levels are suppressed by HBV replication and/or gene expression; the effect on apoB mRNA may be cell type dependent. The compact viral genome contains four well-characterized transcripts that encode various viral proteins (14) ; the largest, the pregenomic, RNA also serves as the template for viral replication. The results obtained with the AD38 cells implicate the pregenomic RNA in apolipoprotein mRNA reduction, although an additional role for subgenomic transcripts is not excluded. Understanding the mechanism(s) of virus-induced changes in apolipoprotein mRNA levels will require further analysis.
A direct effect of viral infection on differentiated hepatocyte function does not fit neatly into the paradigm of chronic HBV as a disease of inflammation. However, reports in the clinical literature are consistent with our in vitro observations. The levels of the circulating HDL and HDL components apoAI and apoAII are reduced during acute hepatitis, when virus levels are high, and normalize with viral clearance (10, 18) . In chronic HBV infection, reduced levels of circulating lipoproteins and apolipoproteins have been correlated with increased viral replication (4, 7, 8, 12) . In the context of chronic HBV infection, even modest reductions in apoAI, a key contributor to the anti-inflammatory activity of HDL (3, 6) , may exacerbate the ongoing inflammatory response in an infected liver. Under the prevailing paradigm of chronic HBV disease, a reduction in liver-derived plasma proteins would be attributed to the immunologically driven turnover of the virus-infected cells. We propose that HBV also has cell-autonomous effects that alter the properties of infected hepatocytes in important ways despite lacking overt cytopathogenicity. 
